ReferenceRRK6626

AN OBSERVER-BLIND RANDOMIZED STUDY WITH AN OPEN-LABEL PART TO EVALUATE THE SAFETY TOLERABILITY PHARMACOKINETICS AND PHARMACODYNAMICS OF SUBCUTANEOUS ADMINISTRATION OF RO7191863 WITH MULTIPLE DOSES AND DIFFERENT REGIMENS IN VIROLOGICALLY SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B INFECTION

Research Summary

Research Overview
PI Name Mutimer - DJ
Speciality
Sponsor F. Hoffman-La Roche
Project Status Open
Proposed End Date 01/03/2022
Study Run through CRF? Yes
Target number of patients agreed to recruit 1
Recruitment so far 0